Directorio de fecha 05/12/2011 - CDCH-UCV
Directorio de fecha 05/12/2011 - CDCH-UCV
Directorio de fecha 05/12/2011 - CDCH-UCV
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
-49- Lehmann ML, Selinski S, Blaszkewicz M, Orlich M, Ovsiannikov D, MoormannO, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G,Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Sei<strong>de</strong>l T, Roth G,Dietrich H, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A,Klein T, Reckwitz T, Roemer HC, Löhlein D, Weistenhöfer W, Schöps W, BegAE, Aslam M, Bánfi G, Romics I, Ickstadt K, Schwen<strong>de</strong>r H, Winterpacht A,Hengstler JG, Golka (2010). Rs71<strong>05</strong>21[A] on chromosome 3q28 close to TP63 isassociated with increased urinary blad<strong>de</strong>r cancer risk. Arch. Toxicol. 84(<strong>12</strong>):967-978. Silvia Selinski;Marie-Louise Lehmann;Meinolf Blaszkewicz; DanielOvsiannikov;Oliver Moormann;Christoph Guballa;Alexan<strong>de</strong>r Kress;Michael C. Truß;HolgerGerullis;Thomas Otto;Dimitri Barski;Günter Niegisch;Peter Albers;SebastianFrees;Walburgis Brenner;Joachim W. Thüroff; Miriam Angeli-Greaves;ThiloSei<strong>de</strong>l;Gerhard Roth;Frank Volkert;Rainer Ebbinghaus;Hans M. Prager;CordulaLukas;Hermann M. Bolt;Michael Falkenstein;Anna Zimmermann;TorstenKlein;Thomas Reckwitz;Hermann C. Roemer;Mark Hartel;WobbekeWeistenhöfer;Wolfgang Schöps;Syed Adibul Hassan Rizvi;MuhammadAslam;Gergely Bánfi;Imre Romics;Katja Ickstadt;Jan G. Hengstler;Klaus Golka(<strong>2011</strong>). Urinary blad<strong>de</strong>r cancer risk in relation to a single nucleoti<strong>de</strong>polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3(IGFBP3) gene, Arch Toxicol. DOI 10.1007/s00204-011-0747-5. PublicadoOnline. Silvia Selinski, Meinolf Blaszkewicz, Marie-Louise Lehmann, DanielOvsiannikov, Oliver Moormann, Christoph Guballa, Alexan<strong>de</strong>r Kress, Michael C.Truß, Holger Gerullis, Thomas Otto, Dimitri Barski, Günter Niegisch, PeterAlbers, Sebastian Frees, Walburgis Brenner, Joachim W. Thüroff, Miriam Angeli-Greaves, Thilo Sei<strong>de</strong>l, Gerhard Roth, Holger Dietrich, Rainer Ebbinghaus, HansM. Prager, Hermann M. Bolt 1 , Michael Falkenstein, Anna Zimmermann, ThorstenKlein, Thomas Reckwitz, Hermann C. Roemer, Dietrich Löhlein, WobbekeWeistenhöfer, Wolfgang Schöps, S. Adibul Hassan Rizvi, Muhammad Aslam,Gergely Bánfi, Imre Romics, Michael Steffens, Arif B. Ekici, AndreasWinterpacht, Katja Ickstadt, Holger Schwen<strong>de</strong>r, Jan G. Hengstler, Klaus Golka(<strong>2011</strong>). Genotyping NAT2 with only two SNPs (rs1041983 and rs180<strong>12</strong>80)outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype Pharmacogenetics and Genomics. (aceptado parapublicación el 22 <strong>de</strong> Abril, <strong>2011</strong> ) Klaus Golka, Yael Abreu-Villaca, Rowshanak Anbari Attar, Miriam Angeli-Greaves, Muhammad Aslam, Nursen Basaran, Rouslana Belik, ChaniphunButryee, Orietta Dalpiaz, Keneshbek Dzhusupov, Thorsten H. Ecke, HenrietaGalambos, Helena Gerilovica, Holger Gerullis, Patricia Casares González, MariaE. Goossens, Lela Gorgishvili-Hermes, Chris F. Heyns, Jasmin Hodzic, FumihikoIkoma, Patrice Jichlinski, Boo-Hyon Kang, Ernst Kiesswetter, Kannan
Change language